Updated on 18 February 2014
The court, however, clarified that nothing observed by it is a final opinion of it on the merits of any disputes between the two organizations. And the application was disposed of only on a prima fascia view of the matter.
Invitrogen Corporation, the US based company that had changed its name to Life Technologies Corporation (LTC) in November 2008 has been acquired by Thermo Fisher Scientific Inc., USA. Thermo Fisher Scientific, the world leader in supplier, on February 4, 2014 announced that it has completed its acquisition of LTC for $76.13 in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of $1.5 billion in net debt. The completion of the transaction follows the receipt of all required regulatory approvals.